Morgan Stanley <MS.N>: BMO raises target price to $250 from $240
MS•Related News
Mineralys Therapeutics publishes corporate presentation on lorundrostat for uncontrolled, resistant hypertension and cardiorenal diseases
MLYS•
New attacks on shipping as Iran war talks hit fresh impasse
XLE•
BridgeBio Pharma, Inc. <BBIO.O>: JP Morgan raises target price to $111 from $100
BBIO•
Helios Technologies Inc <HLIO.N>: JPMorgan raises target price to $110 from $100
HLIO•
Implats flags FY2026 HEPS surge to R2,429-R2,652 cents per share
IMPUY•